Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis

IMPORTANCE: In recent years, significant progress has been made in the pharmacologic treatment of heart failure (HF) with reduced ejection fraction (HFrEF), but there is still insufficient evidence for drug therapy for HF with preserved ejection fraction (HFpEF) and mildly reduced ejection fraction...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Boyang, Zhang, Ruiqi, Wu, Xiaoguang, Zhou, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490501/
https://www.ncbi.nlm.nih.gov/pubmed/36125813
http://dx.doi.org/10.1001/jamanetworkopen.2022.31963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490501/
https://www.ncbi.nlm.nih.gov/pubmed/36125813
http://dx.doi.org/10.1001/jamanetworkopen.2022.31963

Ejemplares similares